Literature DB >> 34514762

Evaluation of the Anti-Müllerian Hormone and its Association with Embryo Quality in Advanced Reproductive Treatments in a Latin American Population.

Héctor Salvador Godoy Morales1, Germán Gabriel Palacios López2, Daniel Vieyra Cortés3, Griselda Claribel Reyes Torres4, Hilda Sanchez Hernández4, Miguel Loyo Guiot4, Francisco Miguel Rojas Camacho4, Gabriela Ayala Montoya4, Berenice Flores Maldonado4.   

Abstract

OBJECTIVE: Serum anti-Müllerian hormone (AMH) presents a strong positive correlation with quantitative aspects of the ovarian reserve, while its correlation with embryo quality is unclear. This study assessed the association between serum AMH as a marker of ovarian reserve and embryo quality, in women undergoing in vitro fertilization.
METHODS: This observational analytical retrospective study included patients seen between 2010 and 2018. In vitro fertilization patients with measured AMH levels were analyzed based on the following parameters: number of retrieved oocytes; number of metaphase II oocytes; embryo quality; and treatment outcome. Statistical analysis was performed using ANOVA, Mann-Whitney U test, linear regression, and Pearson and Spearman correlations.
RESULTS: We found a positive correlation between AMH levels, number of retrieved oocytes and number of metaphase II oocytes (r 0.649, p=0.000). The numbers of retrieved and metaphase II oocytes were predicted in 42% (R2: 429) of the cases based on AMH levels (p=0.000). Serum AMH levels were not associated with embryo quality on Day 3 (p=0.151); an association was seen between AMH levels and embryo quality on Day 5 (p=0.006). The distribution of AMH levels was the same across patients, regardless of whether they were able to achieve pregnancy (p=0.767).
CONCLUSIONS: AMH levels correlated with embryo quality on Day 5; no association was found between AMH levels and embryo quality on Day 3 or pregnancy rate. The use of AMH levels to predict embryo quality still requires further studies; therefore, AMH should be used to assess the ovarian reserve only.

Entities:  

Keywords:  advanced reproductive treatments; anti-Müllerian hormone; embryo quality; ovarian reserve

Mesh:

Substances:

Year:  2022        PMID: 34514762      PMCID: PMC8769191          DOI: 10.5935/1518-0557.20210050

Source DB:  PubMed          Journal:  JBRA Assist Reprod        ISSN: 1517-5693


  10 in total

1.  Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Authors:  Jesper M J Smeenk; Fred C G J Sweep; Gerhard A Zielhuis; Jan A M Kremer; Chris M G Thomas; Didi D M Braat
Journal:  Fertil Steril       Date:  2006-11-01       Impact factor: 7.329

Review 2.  Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.

Authors:  Reshef Tal; Oded Tal; Benjamin J Seifer; David B Seifer
Journal:  Fertil Steril       Date:  2014-10-24       Impact factor: 7.329

3.  Anti-mullerian hormone as a marker of ovarian reserve.

Authors:  Kelton P Tremellen; Michele Kolo; Alan Gilmore; Dharmawijaya N Lekamge
Journal:  Aust N Z J Obstet Gynaecol       Date:  2005-02       Impact factor: 2.100

4.  Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

Authors:  David B Seifer; David T MacLaughlin; Benjamin P Christian; Bo Feng; Robert M Shelden
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

5.  Anti-Müllerian hormone and its role in ovarian function.

Authors:  Maria J G Gruijters; Jenny A Visser; Alexandra L L Durlinger; Axel P N Themmen
Journal:  Mol Cell Endocrinol       Date:  2003-12-15       Impact factor: 4.102

6.  AMH as a Prognostic Factor for Blastocyst Development.

Authors:  Emily De Conto; Vanessa Krebs Genro; Daniela Scherer da Silva; Rita de Cassia Borges Chapon; João Sabino Lahorgue Cunha-Filho
Journal:  JBRA Assist Reprod       Date:  2015-08-01

7.  Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

Authors:  S Lie Fong; E B Baart; E Martini; I Schipper; J A Visser; A P N Themmen; F H de Jong; B J C M Fauser; J S E Laven
Journal:  Reprod Biomed Online       Date:  2008-05       Impact factor: 3.828

8.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

9.  It's Never over until It's over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH-A Study of 5069 Romanian Women.

Authors:  Bogdan Doroftei; Cristina Mambet; Mihaela Zlei
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

10.  The relationship between anti-Müllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART).

Authors:  Shalini Umarsingh; Suresh Babu Naidu Krishna; Jamila Khatoon Adam
Journal:  PeerJ       Date:  2020-12-22       Impact factor: 2.984

  10 in total
  1 in total

1.  Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.

Authors:  Xin Liu; Ying Han; Xinyan Wang; Yunshan Zhang; Aijun Du; Ruqiang Yao; Jiabei Lv; Haining Luo
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-02       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.